当前位置: X-MOL 学术Stem Cell Rev and Rep. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Nanoconjugates-Based Stem Cell Therapy for the Management of COVID-19
Stem Cell Reviews and Reports ( IF 4.8 ) Pub Date : 2020-11-07 , DOI: 10.1007/s12015-020-10079-6
Drashti Desai 1 , Pravin Shende 1
Affiliation  

A potential ability of stem cells (SCs) is to regenerate and repair tissues in the human body by providing great prospects for therapeutic applications in the field of medicine. Currently, SC therapy is used in various conditions like diabetes, neurodegenerative disorders, etc. but faces some limitations like patient biocompatibility and chances of cross-infection. SCs are further modulated with nanoconjugates to overcome such challenges and will offer an advantage in the treatment of COVID-19. This pandemic requires design and development of proper treatment to save the life of human beings. Advancements in SC-based nanoconjugated therapy will open new avenues and create a significant impact in the development of futuristic nanomedicine. It may also emerge as a potential therapy for the management of infection in patients suffering from SARS-CoV-2 and related diseases such as pneumonia and virus-induced lung injuries.



中文翻译:

用于管理 COVID-19 的基于纳米偶联物的干细胞疗法

干细胞(SCs)的一个潜在能力是通过为医学领域的治疗应用提供巨大的前景来再生和修复人体内的组织。目前,SC 疗法用于糖尿病、神经退行性疾病等各种疾病,但面临一些限制,例如患者的生物相容性和交叉感染的机会。SCs 进一步用纳米缀合物调制以克服这些挑战,并将在 COVID-19 的治疗中提供优势。这种流行病需要设计和开发适当的治疗方法来挽救人类的生命。基于 SC 的纳米共轭疗法的进步将开辟新的途径,并对未来纳米医学的发展产生重大影响。

更新日期:2020-11-09
down
wechat
bug